jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) has raised expectations for its experimental weight loss pill, orforglipron, capitalizing $548.1M…
Rimma_Bondarenko/iStock via Getty ImagesEli Lilly (NYSE:LLY) shares sold off on Tuesday after the Indiana-based pharma giant’s Q4 and 2024 preliminary…